相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metformin Does Not Affect Cancer Risk: A Cohort Study in the UK Clinical Practice Research Datalink Analyzed Like an Intention-to-Treat Trial
Konstantinos K. Tsilidis et al.
DIABETES CARE (2014)
Diabetes mellitus and cancer risk: Review of the epidemiological evidence
Kentaro Shikata et al.
CANCER SCIENCE (2013)
Cohort Study of Insulin Glargine and Risk of Breast, Prostate, and Colorectal Cancer Among Patients With Diabetes
Laurel A. Habel et al.
DIABETES CARE (2013)
Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus
H. Qiu et al.
DIABETES OBESITY & METABOLISM (2013)
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2013)
Metformin and Sulfonylureas in Relation to Cancer Risk in Type II Diabetes Patients: A Meta-analysis using primary data of published studies
Bindiya Thakkar et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2013)
Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review
Monica Franciosi et al.
PLOS ONE (2013)
Diabetes and breast cancer risk: a meta-analysis
P. Boyle et al.
BRITISH JOURNAL OF CANCER (2012)
Components of metabolic syndrome and risk of breast cancer by prognostic features in the study of osteoporotic fractures cohort
Katherine W. Reeves et al.
CANCER CAUSES & CONTROL (2012)
Cancer occurrence in Danish diabetic patients: duration and insulin effects
B. Carstensen et al.
DIABETOLOGIA (2012)
Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study
R. Ruiter et al.
DIABETOLOGIA (2012)
Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence
J. A. Johnson et al.
DIABETOLOGIA (2012)
The Influence of Type 2 Diabetes and Glucose-Lowering Therapies on Cancer Risk in the Taiwanese
Ming-Chia Hsieh et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
Oral Insulin Secretagogues, Insulin, and Cancer Risk in Type 2 Diabetes Mellitus
Chia-Hsuin Chang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Diabetes, Metformin, and Breast Cancer in Postmenopausal Women
Rowan T. Chlebowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
Hiroshi Noto et al.
PLOS ONE (2012)
Systematic Review and Meta-analysis of Insulin Therapy and Risk of Cancer
Mohsen Janghorbani et al.
HORMONES & CANCER (2012)
Metabolic Syndrome and Triple-Negative Breast Cancer: A New Paradigm
Andrew A. Davis et al.
INTERNATIONAL JOURNAL OF BREAST CANCER (2012)
Understanding the benefit of metformin use in cancer treatment
Ryan J. O. Dowling et al.
BMC MEDICINE (2011)
The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells
Alejandro Vazquez-Martin et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Risk of Breast Cancer After Onset of Type 2 Diabetes Evidence of detection bias in postmenopausal women
Samantha L. Bowker et al.
DIABETES CARE (2011)
Insulin-like Growth Factor-Dependent Proliferation and Survival of Triple-Negative Breast Cancer Cells: Implications for Therapy
Zoe Davison et al.
NEOPLASIA (2011)
The association of metabolic syndrome with triple-negative breast cancer
B. Maiti et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Linking diabetes and cancer: a consensus on complexity
Andrew Renehan et al.
LANCET (2010)
Metformin induces unique biological and molecular responses in triple negative breast cancer cells
Bolin Liu et al.
CELL CYCLE (2009)
Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study
Adam G. Tabak et al.
LANCET (2009)
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
I. Ben Sahra et al.
ONCOGENE (2008)
Epidemiology of basal-like breast cancer
Robert C. Millikan et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Disrupting insulin-like growth factor signaling as a potential cancer therapy
Deepali Sachdev et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Comparison of the mitogenic potency of regular human insulin and its analogue glargine in normal and transformed human breast epithelial cells
K. Staiger et al.
HORMONE AND METABOLIC RESEARCH (2007)
分享论文
